- Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint
- Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting
- Jacobio Pharma Announces 2023 Annual Results
- Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30300 in the U.S.
Key statistics
As of last trade, Jacobio Pharmaceuticals Group Co Ltd (1167:HKG) traded at 1.81, 31.16% above the 52 week low of 1.38 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.89 |
---|---|
High | 1.89 |
Low | 1.80 |
Bid | 1.79 |
Offer | 1.82 |
Previous close | 1.89 |
Average volume | 1.73m |
---|---|
Shares outstanding | 791.76m |
Free float | 442.77m |
P/E (TTM) | -- |
Market cap | 1.49bn HKD |
EPS (TTM) | -0.5008 HKD |
Data delayed at least 15 minutes, as of May 23 2024 06:32 BST.
More ▼